Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

Medicine, Oncology, Pharmacology +14

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

Richard V. Parry, Jens M. Chemnitz, Kenneth A. Frauwirth et al. · Molecular and Cellular Biology · 2005 · 1.9K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

Weiyi Peng, Jie Qing Chen, Chengwen Liu et al. · Cancer Discovery · 2015 · 1.5K citations · Full text

Medicine, Immunology, Oncology +17

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Andrew T. Parsa, James S. Waldron, Amith Panner et al. · Nature Medicine · 2006 · 1.4K citations

Medicine, Cancer Biology, Oncology +14